Physician

Gisa-Beate A Schunn, M.D.

According to 2025 Medicare claims, Gisa-Beate Schunn, M.D. (NPI: 1144283557) practices hematology/oncology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is VIRGINIA CANCER INSTITUTE INCORPORATED (NPI: 1730130980; TIN: 54-1066435) and primary practice location at 23235-4730.

Schunn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 548 traditional Medicare patients, billed 169,241 HCPCS/CPT codes, and received $1,954,427 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,210 prescription claims across 171 beneficiaries totaling $1,684,055 in drug costs, led by Revlimid (Lenalidomide). 2018 DME data shows 11 claims. Open Payments data shows 100 records totaling $2,224. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $972,132 to $1,954,427. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $770,986 to $1,684,055. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $972,132 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,466,708 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,688,780 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,677,322 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,674,436 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,160,911 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,625,156 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,842,315 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,017,189 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,954,427 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201564139,353$972,132
201662288,968$1,466,708
2017646106,637$1,688,780
2018814205,508$2,677,322
2019771158,995$2,674,436
2020667155,032$3,160,911
2021658151,515$2,625,156
2022683167,334$2,842,315
2023551107,296$2,017,189
2024548169,241$1,954,427

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $770,986 (USD; Tot_Drug_Cst)2016 Drug cost: $804,420 (USD; Tot_Drug_Cst)2017 Drug cost: $1,090,638 (USD; Tot_Drug_Cst)2018 Drug cost: $1,149,876 (USD; Tot_Drug_Cst)2019 Drug cost: $1,456,469 (USD; Tot_Drug_Cst)2020 Drug cost: $1,926,030 (USD; Tot_Drug_Cst)2021 Drug cost: $2,204,146 (USD; Tot_Drug_Cst)2022 Drug cost: $1,399,239 (USD; Tot_Drug_Cst)2023 Drug cost: $1,622,034 (USD; Tot_Drug_Cst)2024 Drug cost: $1,684,055 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151481,139$770,986
20161431,229$804,420
20171681,300$1,090,638
20181771,727$1,149,876
20191741,636$1,456,469
20201571,382$1,926,030
20211731,426$2,204,146
20221571,216$1,399,239
20231641,296$1,622,034
20241711,210$1,684,055

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.1K$6.2K2015 Medicare payment: $6,156 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,262 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R150$6,156
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$3,262
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more82252$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more225559$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more205343$63
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's141209$12
96372Injection of drug or substance under skin or into muscle96286$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide13350$383,850
PomalystPomalidomide12336$271,265
JaypircaPirtobrutinib12360$234,012
ImbruvicaIbrutinib12360$203,799
JakafiRuxolitinib Phosphate15450$202,549

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.100$2,224AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gisa-Beate A. Schunn, M.D.?

Tedicare shows public-source Medicare data for Gisa-Beate A. Schunn, M.D. (NPI 1144283557), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gisa-Beate A. Schunn, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gisa-Beate A. Schunn, M.D.?

Gisa-Beate A. Schunn, M.D. is linked to VIRGINIA CANCER INSTITUTE INCORPORATED (billing NPI 1730130980) in the available physician profile data.

Does Gisa-Beate A. Schunn, M.D. have Open Payments data?

Gisa-Beate A. Schunn, M.D. has 100 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.